31.2304° n, 121.4737° e asia pacific innovation …...asia pacific innovation center shanghai...
TRANSCRIPT
Asia Pacific Innovation Center
Shanghai31.2304° N, 121.4737° E
Early-Stage Collaborations Across All Sectors
If you are an early-stage biopharmaceutical, medical device, or a consumer company seeking a collaboration to advance a program which is pre-proof of concept in humans, make the connection with our Johnson & Johnson Innovation team. Our regional Innovation Centers are located around the globe in the life science hot spots of Asia Pacific, Boston, California and London. Each Innovation Center houses science and technology experts and has full and broad dealmaking capabilities, with flexibility to adapt deal structures and bring together resources from across our company, including:
- Early-stage research funding
- Licensing and collaborations
- Financing from Seed to Series B equity investments
- Cross-sector expertise
- International markets expertise
- Pricing and reimbursement
- Market testing
The teams located at the Johnson & Johnson Innovation Centers are interested in building relationships with regional entrepreneurs at startup companies, universities and institutes who are developing early-stage innovations that are pre-proof of concept in humans across Pharmaceuticals, Medical Devices and Consumer sectors.
THERAPEUTIC AREA AND BUSINESS UNIT SCIENTIFIC LEADS
NEW VENTURES AND TRANSACTIONS
Shanghai Asia Pacific Innovation CenterA regional hub for collaborations throughout AsiaBuilding A, Xinyan Mansion, No. 65, Guiqing Rd., Xuhui District, Shanghai 200233, China
Dan Wang, MD, MPH, MBA, Head, Johnson & Johnson Innovation, Asia PacificE: [email protected]
Visit www.jnjinnovation.com for more information
* Including Infectious Diseases & Vaccines, Cardiovascular & Metabolism, Neuroscience, and Immunology
© Johnson & Johnson Innovation, LLC 2020
February 2020
Scan our QR code from your WeChat to follow us now!
ONCOLOGY
Stefan Hart, Ph.D. E: [email protected]
CONSUMER
Tyrone Mao, MS E: [email protected]
CROSS-THERAPEUTIC AREAS*
Haifeng Cui, Ph.D. E: [email protected]
LUNG CANCER INITIATIVE, CHINA
Jennifer Yang, Ph.D. E: [email protected]
JLABS @ SHANGHAI
Sharon Chan, DPhil, MBA, MPH E: [email protected]
JJDC
TRANSACTIONS
Andrew Wong, MBA E: [email protected]
Nilesh Wadhwa, MBA E: [email protected]
Elizabeth Wu, Ph.D., MS E: [email protected]
NEW VENTURES, NORTH ASIA
Stephen Lee, Ph.D., MBA E: [email protected]
NEW VENTURES, CHINA
Han Dai, Ph.D. E: [email protected]
Roger Da, MSc, MBA E: [email protected]
NEW VENTURES, JAPAN
Jun Kusunoki, Ph.D. E: [email protected]
Keiko Tamai, Ph.D. E: [email protected]